Endogenous glucocorticoids promote the expansion of myeloid-derived suppressor cells in a murine model of trauma

International Journal of Molecular Medicine

Volumn 30, Issue 2, 2012, Pages 277-282

  Zhang, Kun ^a   Bai, Xiangjun ^a   Li, Renjie ^a   Xiao, Zhengzheng ^a   Chen, Jiajun ^a   Yang, Fan ^a   Li, Zhanfei ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Glucocorticoid; Myeloid derived suppressor cells; Trauma

Indexed keywords

ARGINASE 1; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW INJURY; CELL EXPANSION; CONTROLLED STUDY; DRUG EFFECT; INJURY; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD INJURY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SPLEEN INJURY; SUPPRESSOR CELL; SURVIVAL RATE;

ANIMALS; ANTIGENS, CD11B; ARGINASE; BONE MARROW CELLS; CELLS, CULTURED; GLUCOCORTICOIDS; LEUKOCYTES; MALE; MICE; MICE, INBRED BALB C; MIFEPRISTONE; MYELOID CELLS; RECEPTORS, CELL SURFACE; SPLEEN; WOUNDS AND INJURIES;

EID: 84863549126     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1014     Document Type: Article

References (40)

1. Lenz A, Franklin GA and Cheadle WG: Systemic inflammation after trauma. Injury 38: 1336-1345, 2007.
2. Osborn TM, Tracy JK, Dunne JR, Pasquale M and Napolitano LM: Epidemiology of sepsis in patients with traumatic injury. Crit Care Med 32: 2234-2240, 2004.
3. Nast-Kolb D, Aufmkolk M, Rucholtz S, Obertacke U and Waydhas C: Multiple organ failure still a major cause of morbidity but not mortality in blunt multiple trauma. J Trauma 51: 835-842, 2001.
4. Hoover L, Bochicchio GV, Napolitano LM, et al: Systemic inflammatory response syndrome and nosocomial infection in trauma. J Trauma 61: 310-317, 2006.
5. Keh D, Boehnke T, Weber-Cartens S, et al: Immunologic and hemodynamic effects of 'low-dose' hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 167: 512-520, 2003.
6. Roquilly A, Mahe PJ, Seguin P, et al: Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study. JAMA 305: 1201-1209, 2011.
7. Hoen S, Asehnoune K, Brailly-Tabard S, et al: Cortisol response to corticotropin stimulation in trauma patients: influence of hemorrhagic shock. Anesthesiology 97: 807-813, 2002.
8. Confalonieri M, Urbino R, Potena A, et al: Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 171: 242-248, 2005.
9. Rhen T and Cidlowski JA: Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N Engl J Med 353: 1711-1723, 2005.
10. Ostrand-Rosenberg S and Sinha P: Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 182: 4499-4506, 2009.
11. Gabrilovich DI and Nagaraj S: Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9: 162-174, 2009.
12. Ochoa AC, Zea AH, Hernandez C and Rodriguez PC: Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin Cancer Res 13: S721-S726, 2007.
13. +Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J Immunol 179: 5228-5237, 2007.
14. Delano MJ, Scumpia PO, Weinstein JS, et al: MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med 204: 1463-1474, 2007.
15. + myeloid suppressor cells cause T cell dysfunction after traumatic stress. J Immunol 176: 2085-2094, 2006.
16. Munera V, Popovic PJ, Bryk J, et al: Stat 6-dependent induction of myeloid derived suppressor cells after physical injury regulates nitric oxide response to endotoxin. Ann Surg 251: 120-126, 2010.
17. Bryk JA, Popovic PJ, Zenati MS, Munera V, Pribis JP and Ochoa JB: Nature of myeloid cells expressing arginase 1 in peripheral blood after trauma. J Trauma 68: 843-852, 2010.
18. Cuenca AG, Delano MJ, Kelly-Scumpia KM, et al: A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol Med 17: 281-292, 2011.
19. Varga G, Ehrchen J, Tsianakas A, et al: Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells. J Leukoc Biol 84: 644-650, 2008.
20. Ehrchen J, Steinmuller L, Barczyk K, et al: Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 109: 1265-1274, 2007.
21. Barczyk K, Ehrchen J, Tenbrock K, et al: Glucocorticoids promote survival of anti-inflammatory macrophages via stimulation of adenosine receptor A3. Blood 116: 446-455, 2010.
22. Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332: 1351-1362, 1995.
23. Kashiwabara M, Miyashita M, Nomura T, et al: Surgical trauma-induced adrenal insufficiency is associated with postoperative inflammatory responses. J Nihon Med Sch 74: 274-283, 2007.
24. Marik PE and Zaloga GP: Adrenal insufficiency during septic shock. Crit Care Med 31: 141-145, 2003.
25. Chinenov Y and Rogatsky I: Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network. Mol Cell Endocrinol 275: 30-42, 2007.
26. Baschant U and Tuckermann J: The role of the glucocorticoid receptor in inflammation and immunity. J Steroid Biochem Mol Biol 120: 69-75, 2010.
27. - T cells to dexamethasone-induced cell death. Eur J Immunol 34: 859-869, 2004.
28. Barrera G, Landoni V, Martire-Greco D, et al: Model of polymicrobial peritonitis that induces the proinflammatory and immunosuppressive phases of sepsis. Infect Immun 79: 1280-1288, 2011.
29. Schwacha MG, Thobe BM, Daniel T and Hubbard WJ: Impact of thermal injury on wound infiltration and the dermal inflammatory response. J Surg Res 158: 112-120, 2010.
30. Sander LE, Sackett SD, Dierssen U, et al: Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med 207: 1453-1464, 2010.
31. Rearte B, Maglioco A, Balboa L, et al: Mifepristone (RU486) restores humoral and T cell-mediated immune response in endotoxin immunosuppressed mice. Clin Exp Immunol 162: 568-577, 2010.
32. Ichikawa M, Williams R, Wang L, Vogl T and Srikrishna G: S100A8/A9 activate key genes and signaling pathways in colon tumor progression. Mol Cancer Res 9: 133-148, 2011.
33. Cheng P, Corzo CA, Luetteke N, et al: Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 205: 2235-2249, 2008.
34. Sinha P, Okoro C, Foell D, Freeze HH, Ostrand-Rosenberg S and Srikrishna G: Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol 181: 4666-4675, 2008.
35. Fujita M, Kohanbash G, Fellows-Mayle W, et al: COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells. Cancer Res 71: 2664-2674, 2011.
36. Eruslanov E, Daurkin I, Vieweg J, Daaka Y and Kusmartsev S: Aberrant PGE metabolism in bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cells. Int Immunopharmacol 11: 848-855, 2011.
37. Sinha P, Clements VK, Fulton AM and Ostrand-Rosenberg S: Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res 67: 4507-4513, 2007.
38. Geerts L, Jorens PG, Willems J, De Ley M and Slegers H: Natural inhibitors of neutrophil function in acute respiratory distress syndrome. Crit Care Med 29: 1920-1924, 2001.
39. Chollet-Martin S, Jourdain B, Gibert C, Elbim C, Chastre J and Gougerot-Pocidalo MA: Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am J Respir Crit Care Med 154: 594-601, 1996.
40. Condamine T and Gabrilovich DI: Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol 32: 19-25, 2011.